"Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells that can give rise to cells of the three different GERM LAYERS.
| Descriptor ID |
D039904
|
| MeSH Number(s) |
A11.872.700
|
| Concept/Terms |
Pluripotent Stem Cells- Pluripotent Stem Cells
- Pluripotent Stem Cell
- Stem Cell, Pluripotent
- Stem Cells, Pluripotent
|
Below are MeSH descriptors whose meaning is more general than "Pluripotent Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Pluripotent Stem Cells".
This graph shows the total number of publications written about "Pluripotent Stem Cells" by people in this website by year, and whether "Pluripotent Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pluripotent Stem Cells" by people in Profiles.
-
Biscetti F, Bonadia N, Nardella E, Cecchini AL, Landolfi R, Flex A. The Role of the Stem Cells Therapy in the Peripheral Artery Disease. Int J Mol Sci. 2019 May 07; 20(9).
-
Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, Taubenschmid J, H?mmerle M, Esk C, Bagley JA, Lindenhofer D, Chen G, Boehm M, Agu CA, Yang F, Fu B, Zuber J, Knoblich JA, Kerjaschki D, Penninger JM. Human blood vessel organoids as a?model of?diabetic vasculopathy. Nature. 2019 01; 565(7740):505-510.
-
Lucendo-Villarin B, Filis P, Swortwood MJ, Huestis MA, Meseguer-Ripolles J, Cameron K, Iredale JP, O'Shaughnessy PJ, Fowler PA, Hay DC. Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells. Arch Toxicol. 2017 Nov; 91(11):3633-3643.
-
Wu L, Bluguermann C, Kyupelyan L, Latour B, Gonzalez S, Shah S, Galic Z, Ge S, Zhu Y, Petrigliano FA, Nsair A, Miriuka SG, Li X, Lyons KM, Crooks GM, McAllister DR, Van Handel B, Adams JS, Evseenko D. Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cells. Stem Cell Reports. 2013; 1(6):575-89.
-
Uitto J. Regenerative medicine for skin diseases: iPS cells to the rescue. J Invest Dermatol. 2011 Apr; 131(4):812-4.
-
Markman JL, Silvers RM, Ndoye AM, Geary KR, Alvarado D, Smith JA, Daniel R. HIV-1 integration site preferences in pluripotent cells. Front Biosci (Elite Ed). 2011; 3:453-62.
-
Greenbaum LE. From skin cells to hepatocytes: advances in application of iPS cell technology. J Clin Invest. 2010 Sep; 120(9):3102-5.
-
Smith JA, Ndoye AM, Geary K, Lisanti MP, Igoucheva O, Daniel R. A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4. Aging Cell. 2010 Aug; 9(4):580-91.
-
Harris DT. Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev. 2008 Dec; 4(4):269-74.
-
Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007 Dec; 2(4):301-9.